In this review, we briefly discuss recently published data on female sexual desire, arousal, orgasm and pain, and on medical/iatrogenic factors associated with female sexual function. The studies reviewed highlight a number of important methodological and etiological issues in the study of female sexual function. Researchers are urged to use standardized methods for defining sexual disorders an...

To clarify whether sexual arousal could be enhanced by hypoxia, and to explain the pathogenesis of autoerotic death (AED)/autoerotic asphyxiation (AEA), we investigated the molecular-biological and hormonal interactions in male rats between hypoxia (10% O2) and sexual stimulation (placing male rats with oestrous female rats) using hypothalamus tissue and serum. Serum oxytocin concentration was ...

Sex differences in human sexuality are plentiful and include physical, psychological, and psychophysiological variations (Geary, 1998). Examples include masturbation frequency (Oliver & Hyde, 1993), sex drive (Baumeister et al., 2001), habituation of sexual arousal to sexual stimuli (Laan & Everaerd, 1995a, b; O’Donohue & Geer, 1985), cognition (Geer & Bellard, 1996), self-reported arousal to s...

To date, there has been limited literature on the measurement of sexual arousal in adolescent sex offenders. The data that exist have been somewhat mixed in terms of factors related to deviant sexual arousal in this group. The present study, with 71 adolescent sex offenders, investigates the relationship between offender and offense characteristics, including gender of victim, history of sexual...

Background & aim: Sexual health is an essential element of quality of life, affecting both physical and psychological domains. Hormones used in contraceptive methods have contradictory effects on sexual function. In this study, we aimed to compare sexual function in women using combined oral contraceptives (COC) and depot medroxyprogesterone acetate (DMPA), referred to healthcare centers affili...

AIM Evaluate efficacy/safety of bremelanotide (BMT), a melanocortin-receptor-4 agonist, to treat female sexual dysfunctions in premenopausal women. METHODS Patients randomized to receive placebo or BMT 0.75, 1.25 or 1.75 mg self-administered subcutaneously, as desired, over 12 weeks. Primary end point was change in satisfying sexual events/month. Secondary end points included total score chan...

Self-reports of sexual arousal were significantly affected by conditions under which they were elicited. Such self-reports in women not taking oral contraceptives were congruent with a hormonal basis for such arousal only when the women were "unaware" that the study investigated sexual arousal as a function of the menstrual cycle. The "unaware" condition was operationalized by means of daily se...

background: sexual instinct which is the cause of numerous changes in an individual’s life could be influenced by different factors such as menopause and ageing. this study was designed to compare sexual dysfunction before and after menopause. materials and methods: this was a cross-sectional study. participants were 174 menopausal women who referred to medical health centers of isfahan, iran. ...

Recently, heart rate variability (HRV) level has been found to be a risk factor for female sexual dysfunction. Low HRV was a significant predictor of female sexual arousal dysfunction and overall sexual dysfunction. Building upon this finding, the present study examined whether differences in vagal activity between sexually functional and sexually dysfunctional women may be driving the associat...